SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bhag Karamchandani who wrote (29)4/29/1996 7:08:00 PM
From: Lyle Abramowitz   of 305
 
Bhag, The WSJ briefing book is accessible through the on-line Wall Street Journal which, for now, is a free service. You can get to the online WSJ at update.wsj.com Today they went to a new interactive edition and I've not yet been able to access them. You need to register with them and establish a login and password. When you access the service I think you can get a "snapshot" of most stocks using the ticker symbol. When that comes up i think there is a prompt for the news stories. I'm being a little vague because I haven't yet accessed this new edition. As to what the test results mean... as I indicated I don't know. I might call the company when I have time. My assessment is that it is not good news--ALLERVAX Cat may work but the results are not resounding and larger drug companies may balk at the developing and marketing expenses involved which would leave IMUL on its own to develop an ALLERVAX product line. There were some intimations that one of the reasons Hoechst severed its relationship with IMUL was that they were unimpressed by the potential of the ALLERVAX therapies. I am still long on the stock. As I mentioned in the last post, I don't know enough about clinical drug trials to really know if the product is viable. There is another participant on this string who seems quite knowledgeable,Paul Getman,--perhaps we should seek his opinion.

Regards,
Lyle
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News